SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended from time to time, please find herewith enclosed copy of 01st Quarter of Financial Year 2020-21 Results presentation made to analysts and Investors SHILPA MEDICARE LTD. - 530549 - Outcome Of Board Meeting Held On 08Th August, 2020.
With reference to the captioned subject, Please be noted that pursuant to the Resolution passed at the meeting of the board of directors held on 08th August, 2020 at 03:30 P.M. the following items have taken on record. The unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2020 pursuant to Regulation 33(3) of SEBI (LODR) Regulations, 2015. The meeting commenced at 03:30 PM hours and concluded at 6:00 PM. This is for your information and necessary records. SHILPA MEDICARE LTD. - 530549 - Outcome Of Board Meeting Held On 08Th August, 2020
Dear Sir, With reference to the captioned subject, Please be noted that pursuant to the Resolution passed at the meeting of the board of directors held on 08th August, 2020 at 03:30 P.M. the following items have taken on record. The unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2020 pursuant to Regulation 33(3) of SEBI (LODR) Regulations, 2015. The meeting commenced at 03:30 PM hours and concluded at 6:00 PM. This is for your information and necessary records SHILPA MEDICARE LTD. - 530549 - Board Meeting Intimation for Sub: Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015- Reg. Ref: Stock Code: NSE: SHILPAMED/BSE-530549
SHILPA MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2020 ,inter alia, to consider and approve With reference to the above subject cited above, we wish to inform you that a meeting of the Board of Directors of Shilpa Medicare Limited will be held on Saturday, the 08th Day of August, 2020 to inter alia to transact the following items of business: Approval of the unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June, 2020. This is for your information and records SHILPA MEDICARE LTD. - 530549 - Submission Of Revised Compliance Certificate For The Half Year Ended 31St March, 2020
with reference to the mail dated 23rd july, by Mr. Rakesh Parekh, Special Assistant, listing compliance, BSE Limited, please find herewith attached signed certificate from practicing Company Secretaries, M/s P.S Rao and Associates under Regulation 40(9) of SEBI (LODR) Regulations, 2015. SHILPA MEDICARE LTD. - 530549 - Shareholding for the Period Ended June 30, 2020
Shilpa Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here SHILPA MEDICARE LTD. - 530549 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0440 Name of the Signatory :- Krishna ChaitanyaDesignation :- Company Secretary and Compliance Officer SHILPA MEDICARE LTD. - 530549 - Submission Of Related Party Transactions U/R 23(9) Of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2020
Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find herewith enclosed Related Party Transactions on consolidated basis in the format as per the relevant Accounting Standards for the Half Year ended 31st March, 2020 SHILPA MEDICARE LTD. - 530549 - Closure of Trading Window
With reference to the above subject it is hereby informed that the trading window of Shilpa Medicare Limited will remain closed for dealing in the securities of the Company for all Designated Employees/ Persons and their immediate relatives with effect from 01st July, 2020 till the end of 48 hours from the declaration of the financial results for the First quarter ended 30th June, 2020. This is for your information and records SHILPA MEDICARE LTD. - 530549 - Sub: Non-Applicability Of SEBI Circular-SEBI/HO/DDHS/CIR/P/2018/144 Dated 26.11.2018 Ref: SEBI Circular No. SEBI/HO/DDHS/ON/P/2020/41 Dated 23.03.2020
This has reference to the circular cited above issued by SEBI introducing a framework to identify corporates as Large Corporates (LC) upon fulfillment of criteria prescribed therein and requiring them to ensure consequent compliance. We hereby confirm that the said circular is not applicable to our Company (Shilpa Medicare Limited) as we do not fulfill all the criteria prescribed thereunder per the attachment.